Project Details
Description
A Phase 2/3 Trial Of The Efficacy And Safety Of Bardoxolone Methyl In Patients With Alport Syndrome
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/16 → 6/30/21 |
Funding
- REATA PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.